Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer

Kim N. Chi, Andrew J. Armstrong, Bernd J. Krause, Ken Herrmann, Kambiz Rahbar, Johann S. de Bono, Nabil Adra, Rohan Garje, Jeff M. Michalski, Mette M. Kempel, Karim Fizazi, Michael J. Morris, Oliver Sartor, Marcia Brackman, Michelle DeSilvio, Celine Wilke, Geoffrey Holder, Scott T. Tagawa

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science